130 related articles for article (PubMed ID: 2395088)
1. HLA antigen frequencies in HIV-1-related Kaposi's sarcoma.
Mann DL; Murray C; O'Donnell M; Blattner WA; Goedert JJ
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S51-5. PubMed ID: 2395088
[TBL] [Abstract][Full Text] [Related]
2. HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS.
Mann DL; Murray C; Yarchoan R; Blattner WA; Goedert JJ
J Acquir Immune Defic Syndr (1988); 1988; 1(1):13-7. PubMed ID: 3216293
[TBL] [Abstract][Full Text] [Related]
3. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.
Dorak MT; Yee LJ; Tang J; Shao W; Lobashevsky ES; Jacobson LP; Kaslow RA
J Med Virol; 2005 Jul; 76(3):302-10. PubMed ID: 15902698
[TBL] [Abstract][Full Text] [Related]
4. HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma.
Prince HE; Schroff RW; Ayoub G; Han S; Gottlieb MS; Fahey JL
J Clin Immunol; 1984 May; 4(3):242-5. PubMed ID: 6588054
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group.
Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G
Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573
[TBL] [Abstract][Full Text] [Related]
6. HLA antigens are risk factors for development of AIDS.
Jeannet M; Sztajzel R; Carpentier N; Hirschel B; Tiercy JM
J Acquir Immune Defic Syndr (1988); 1989; 2(1):28-32. PubMed ID: 2783969
[TBL] [Abstract][Full Text] [Related]
7. SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi's sarcoma.
Aissani B; Boehme AK; Wiener HW; Shrestha S; Jacobson LP; Kaslow RA
Genes Immun; 2014 Sep; 15(6):424-9. PubMed ID: 25008864
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study.
Archibald CP; Schechter MT; Craib KJ; Le TN; Douglas B; Willoughby B; O'Shaughnessy M
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S18-23. PubMed ID: 2395081
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma in three HIV-1-infected cohorts.
Rabkin CS; Goedert JJ; Biggar RJ; Yellin F; Blattner WA
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S38-43. PubMed ID: 2395084
[TBL] [Abstract][Full Text] [Related]
11. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5.
Melbye M; Kestens L; Biggar RJ; Schreuder GM; Gigase PL
Int J Cancer; 1987 Feb; 39(2):182-4. PubMed ID: 3492448
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group.
Jacobson LP; Muñoz A; Fox R; Phair JP; Dudley J; Obrams GI; Kingsley LA; Polk BF
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S24-31. PubMed ID: 2395082
[TBL] [Abstract][Full Text] [Related]
13. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.
Klein MR; Keet IP; D'Amaro J; Bende RJ; Hekman A; Mesman B; Koot M; de Waal LP; Coutinho RA; Miedema F
J Infect Dis; 1994 Jun; 169(6):1244-9. PubMed ID: 8195600
[TBL] [Abstract][Full Text] [Related]
14. HLA and Kaposi's sarcoma in Sardinia.
Contu L; Cerimele D; Pintus A; Cottoni F; La Nasa G
Tissue Antigens; 1984 Apr; 23(4):240-5. PubMed ID: 6587615
[TBL] [Abstract][Full Text] [Related]
15. HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections.
Pollack MS; Gold J; Metroka CE; Safai B; Dupont B
Hum Immunol; 1984 Oct; 11(2):99-103. PubMed ID: 6333416
[TBL] [Abstract][Full Text] [Related]
16. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.
Pollack MS; Safai B; Myskowski PL; Gold JW; Pandey J; Dupont B
Tissue Antigens; 1983 Jan; 21(1):1-8. PubMed ID: 6601312
[TBL] [Abstract][Full Text] [Related]
17. Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients.
Gayà A; Esteve A; Casabona J; McCarthy JJ; Martorell J; Schulz TF; Whitby D;
AIDS; 2004 Jan; 18(2):199-204. PubMed ID: 15075536
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations.
Cameron PU; Mallal SA; French MA; Dawkins RL
Hum Immunol; 1990 Dec; 29(4):282-95. PubMed ID: 1981061
[TBL] [Abstract][Full Text] [Related]
19. Possible correlation between exposure to AIDS risk factors, clinical presentation in AIDS, and subsequent prognosis.
Messiah A; Rozenbaum W; Vittecoq D; Brunet JB
Eur J Epidemiol; 1989 Sep; 5(3):336-42. PubMed ID: 2792309
[TBL] [Abstract][Full Text] [Related]
20. Relationship between human leukocyte antigen alleles and risk of Kaposi's sarcoma in Cameroon.
Cornejo Castro EM; Morrison BJ; Marshall VA; Labo N; Miley WJ; Clements N; Nelson G; Ndom P; Stolka K; Hemingway-Foday JJ; Abassora M; Gao X; Smith JS; Carrington M; Whitby D
Genes Immun; 2019 Nov; 20(8):684-689. PubMed ID: 31105266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
